Table 1 Participant characteristics
| Â | South Africa | Uganda |
|---|---|---|
In-depth interviews | N = 20 | N = 22 |
Pregnant | 15 | 9 |
Lactating woman | 5 | 13 |
Age range | ||
 18–24 years | 3 | 2 |
  > 24 years | 17 | 20 |
Education | ||
 Primary | 6 | 10 |
 Secondary/High school | 13 | 8 |
 Post-secondary | 1 | 2 |
Dolutegravir exposure | ||
 Exposed | 8 | 11 |
 Not exposed | 12 | 11 |
Participant type | ||
 DolPHIN-2 trial participants | 8 | 10 |
 Non-trial participants | 12 | 12 |
Focus group discussions | N = 9 | N = 6 |
Gender | ||
 Women | 4 (40 participants) | 3 (27 participants) |
 Men | 5 (59 participants) | 3 (28 participants) |
Age range | ||
 18–24 years | 18 | 10 |
  > 24 years | 81 | 45 |